Paradromics received regulatory approval to test its BCI device in a small clinical trial to assess its safety and efficacy.

Paradromics and Neuralink are leading the race in developing advanced brain implants. Reports highlight differences in ...

Telco extends presence in API arena with two products designed to give businesses practical tools to improve customer experience, while laying the foundation for models of innovation and collaboration ...

The Gemini API improvements include simpler controls over thinking, more granular control over multimodal vision processing, ...

Paradromics Inc., a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, today announced the US FDA has granted Investigational Device Exemption (IDE) ...

Fara-7B is our first agentic small language model for computer use. This experimental model includes robust safety measures ...

To be precise, this is a tiny, IP67-rated box powered by batteries, USB-C, or Power over Ethernet, and it's built around the ...

Paradromics announced that it received FDA investigational device exemption (IDE) to begin a study of its brain-computer ...

Powerful artificial intelligence (AI) systems, like ChatGPT and Gemini, simulate understanding of comedy wordplay, but never really "get the joke," a new study suggests.

Austin-based neurotechnology Paradromics announced that it has received FDA approvals to start its clinical trials.

There has been a lot of discussion across the channel for the need for customers to start the journey to artificial intelligence (AI) by focusing on the data foundations. That challenge is not just a ...